- Home
- PBYI vs BZUN Comparison
PBYI vs BZUN Comparison
Compare PBYI & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- BZUN
- Stock Information
- Founded
- PBYI 2010
- BZUN 2007
- Country
- PBYI United States
- BZUN China
- Employees
- PBYI N/A
- BZUN N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- BZUN Catalog/Specialty Distribution
- Sector
- PBYI Health Care
- BZUN Consumer Discretionary
- Exchange
- PBYI Nasdaq
- BZUN Nasdaq
- Market Cap
- PBYI 171.7M
- BZUN 275.9M
- IPO Year
- PBYI N/A
- BZUN N/A
- Fundamental
- Price
- PBYI $4.64
- BZUN $4.60
- Analyst Decision
- PBYI Strong Buy
- BZUN Strong Buy
- Analyst Count
- PBYI 1
- BZUN 1
- Target Price
- PBYI $7.00
- BZUN $4.20
- AVG Volume (30 Days)
- PBYI 648.1K
- BZUN 703.4K
- Earning Date
- PBYI 11-06-2025
- BZUN 08-28-2025
- Dividend Yield
- PBYI N/A
- BZUN N/A
- EPS Growth
- PBYI 434.29
- BZUN N/A
- EPS
- PBYI 0.97
- BZUN N/A
- Revenue
- PBYI $238,062,000.00
- BZUN $1,349,630,922.00
- Revenue This Year
- PBYI N/A
- BZUN $5.27
- Revenue Next Year
- PBYI N/A
- BZUN $3.46
- P/E Ratio
- PBYI $4.76
- BZUN N/A
- Revenue Growth
- PBYI 8.63
- BZUN 7.73
- 52 Week Low
- PBYI $2.32
- BZUN $2.12
- 52 Week High
- PBYI $6.07
- BZUN $4.88
- Technical
- Relative Strength Index (RSI)
- PBYI 49.99
- BZUN 72.48
- Support Level
- PBYI $4.49
- BZUN $3.74
- Resistance Level
- PBYI $5.22
- BZUN $4.88
- Average True Range (ATR)
- PBYI 0.26
- BZUN 0.34
- MACD
- PBYI -0.12
- BZUN 0.12
- Stochastic Oscillator
- PBYI 22.33
- BZUN 87.04
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.